Cancer Evolution during Immunotherapy

Cell
M C Andrews, Jennifer A Wargo

Abstract

Immune checkpoint blockade has revolutionized cancer treatment. In this issue of Cell, insights from a longitudinal multi-omics analysis of the largest yet-reported cohort of melanoma patients reveal how tumor and immunity co-evolve during anti-PD-1 therapy.

Citations

Jul 4, 2018·Acta Pharmacologica Sinica·Ying-Qiang LiuJian Ding
Jun 21, 2020·Nature Communications·Ping ZhangChunhai Fan
Aug 21, 2019·Frontiers in Immunology·Zhi-Liang WangTao Jiang
Oct 10, 2020·Journal of Cancer Prevention·Kyle J Gu, Guojun Li
Jun 26, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cong LiYihui Deng
Aug 20, 2021·Chembiochem : a European Journal of Chemical Biology·Lujia HuangHaijun Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.